7+3 (chemotherapy)

Acute myelogenous leukemia induction therapy regimen

"7+3" in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today as first-line induction therapy in acute myelogenous leukemia, excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy.

This keyword could refer to multiple things. Here are some suggestions: